Search research articles
Contact Us
Filters
Showing results (1-10 of 144) with videos related to
Page
of 15
Sort By:
Nebraska Nurse
|
August 1, 1997
Nurses promote breast health
B Rettig
Clinical Advances in Hematology & Oncology : H&O
|
March 15, 2022
Highlights in prostate cancer from the 2021 European Society for Medical Oncology Congress and the 2021 American Urological Association Meeting: commentary
Matthew B Rettig
Clinical Advances in Hematology & Oncology : H&O
|
May 17, 2022
How patient characteristics can guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Matthew B Rettig
Nature Biotechnology
|
October 23, 1997
Interleukin-6: an antagonizing problem becomes a solution
M B Rettig
The Nebraska Medical Journal
|
February 1, 1995
Breast cancer screening in Nebraska: an update
B Rettig, M Horton
The Nebraska Medical Journal
|
March 1, 1996
Breast cancer in Nebraska: recent trends in incidence, mortality, and screening
B Rettig, M Horton
Der Anaesthesist
|
February 1, 1980
[Malignant hyperthermia. A case report (author's transl)]
B Rettig, H Weitz
Molecular Cancer Therapeutics
|
January 24, 2007
Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib
Jiabin An, Matthew B Rettig
Molecular and Cellular Biology
|
August 19, 2005
Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
Jiabin An, Matthew B Rettig
The Nebraska Medical Journal
|
July 1, 1994
Breast cancer screening: recent trends in the use of mammography in Nebraska
B Rettig, N Nelson, R Faulk
Page
of 15
Search research articles
Search
Showing results (1-10 of 144) with videos related to
Sort By:
Page
of 15
Nebraska Nurse
|
August 1, 1997
Nurses promote breast health
B Rettig
Clinical Advances in Hematology & Oncology : H&O
|
March 15, 2022
Highlights in prostate cancer from the 2021 European Society for Medical Oncology Congress and the 2021 American Urological Association Meeting: commentary
Matthew B Rettig
Clinical Advances in Hematology & Oncology : H&O
|
May 17, 2022
How patient characteristics can guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Matthew B Rettig
Nature Biotechnology
|
October 23, 1997
Interleukin-6: an antagonizing problem becomes a solution
M B Rettig
The Nebraska Medical Journal
|
February 1, 1995
Breast cancer screening in Nebraska: an update
B Rettig, M Horton
The Nebraska Medical Journal
|
March 1, 1996
Breast cancer in Nebraska: recent trends in incidence, mortality, and screening
B Rettig, M Horton
Der Anaesthesist
|
February 1, 1980
[Malignant hyperthermia. A case report (author's transl)]
B Rettig, H Weitz
Molecular Cancer Therapeutics
|
January 24, 2007
Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib
Jiabin An, Matthew B Rettig
Molecular and Cellular Biology
|
August 19, 2005
Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
Jiabin An, Matthew B Rettig
The Nebraska Medical Journal
|
July 1, 1994
Breast cancer screening: recent trends in the use of mammography in Nebraska
B Rettig, N Nelson, R Faulk
Page
of 15